Meropenem and continuous renal replacement [2]

Critical Care Medicine

Volumn 29, Issue 8, 2001, Pages 1653-1654

  Thalhammer, F ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MEROPENEM;

ANTIBIOTIC PROPHYLAXIS; DOSE CALCULATION; DRUG CLEARANCE; GRAM NEGATIVE INFECTION; HEMOFILTRATION; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; LETTER; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0034883999     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200108000-00037     Document Type: Letter

References (8)

1. Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration
2. Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration
3. Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration
4. Meropenem pharmacokinetics in a patient with multiorgan failure from meningococcemia undergoing continuous venovenous hemodiafiltration
5. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration
6. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous renovenous hemofiltration or hemodiafiltration
7. Elimination of meropenem during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure
8. Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy